lea ament, left, and tamara nunley talk about the care their team provided for helen and robert valenzuela at st. jude medical center in fullerton. (scott smeltzer / staff photographer)
.
.
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.
.
.
.
crispr therapeutics, mgh team up on new cancer treatments
.
.
.